Patents by Inventor Mark A. Jackson

Mark A. Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10353273
    Abstract: A screen is provided. The screen includes: a substrate; an adhesive affixed to the substrate; and a mixture of reflective beads and transparent beads affixed by the adhesive to the substrate.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: July 16, 2019
    Assignee: MAGIC MEMORIES INNOVATION LIMITED
    Inventor: Kevin Mark Jackson
  • Patent number: 10350202
    Abstract: Compositions and methods for treatment of conditions affecting skin and/or mucosal surfaces of a subject that make use of an imidazoquinoline compound and a retinoid agent are described.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: July 16, 2019
    Assignee: 442 Ventures, LLC
    Inventor: J. Mark Jackson
  • Publication number: 20190175169
    Abstract: Suture passer systems for tissue suspension and tissue compression, and more particularly for tongue suspension, are described. The system can include at least a first elongate tubular body or shaft, a needle having a lateral bias carried by the elongate body, and a retrieval element operably connected to the elongate tubular body. The needle can have a substantially straight configuration when located within the elongate tubular body, and be configured to exit an opening at or near a distal end of the elongate tubular body and assume a laterally biased or curved shape to form a path through tissue. The needle is configured to carry a suture. The retrieval element can be configured to retrieve the suture carried by the needle after the needle has formed a curved or otherwise angled path through tissue. The system can also include one or more bone anchors to secure the suture loops. Methods of placing one or more suture loops into tissue, such as the base of the tongue, are also described.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 13, 2019
    Inventors: Erik van der Burg, Peter Martin, Chris Feezor, Mark Hirotsuka, Jasper Jackson, Christopher T. Cheng, Michael Kolber, Adam H. Liston
  • Publication number: 20190168021
    Abstract: An optogenetic system and method for preventing or halting seizures. The system and method use a sensor for monitoring the activity of a neural network containing a group of target neurons, and generating an input signal indicative of said activity, the target neurons being excitatory neurons. Excitatory stimulation is delivered in the form of an optical signal by an optical stimulator to the target neurons, the optical signal being determined based on the input signal, to reduce the overall activity of the target neurons.
    Type: Application
    Filed: July 28, 2017
    Publication date: June 6, 2019
    Applicant: University of Newcastle Upon Tyne
    Inventors: Andrew Jackson, Mark Cunningham, Stuart Baker, Patrick Degenaar
  • Publication number: 20190144443
    Abstract: The invention relates to compound of formula (I): A-X1-L-X2—B?? (I) and salts, solvates and tautomers thereof, which are useful as medicaments, in particular as anti-proliferative agents and for use as a drug in an antibody-drug conjugate; wherein A is a group selected from: X1 and X2 are independently selected from O, S, NR28, CR28R29, CR28R29O, C(?O), C(?O)NR28, NR28C(?O), C(O)—RA—C(O)—NH, C(O)—RA—NH—C(O), C(O)—NH—RA—C(O), NH—C(O)—RA—C(O), NH—C(O)—RA—C(O)—NH, NH—C(O)—RA—NH—C(O), C(O)—NH—RA—NH—C(O), C(O)—NH—RA—C(O)—NH, O—C(O) and C(O)—O or is absent; L is selected from an amino acid, a peptide chain having from 2 to 12 amino acids, a paraformaldehyde chain —(OCH2)1-24—, a polyethylene glycol chain —(OCH2CH2)1-12— and —(CH2)m—Y6—(CH2)n— wherein Y6 is selected from —(CH2)z— and a group (L1) a group (L1) that is selected from arylene, monocyclic heteroarylene, monocyclic cycloalkylene, monocyclic cycloalkenylene and monocyclic heterocyclylene groups optionally substituted with up to three optional subst
    Type: Application
    Filed: November 13, 2018
    Publication date: May 16, 2019
    Inventors: Paul Joseph Mark Jackson, David Edwin Thurston, Khondaker Mirazur Rahman
  • Publication number: 20180339985
    Abstract: The invention relates to pyrridinobenzodiazepines (PDDs) comprising three fused 6-7-6-membered rings linked to aromatic groups, and pharmaceutically acceptable salts thereof, which are useful as medicaments, such as anti-proliferative agents.
    Type: Application
    Filed: April 14, 2018
    Publication date: November 29, 2018
    Inventors: Paul Joseph Mark JACKSON, David Edwin THURSTON, Khondaker Mirazur RAHMAN
  • Publication number: 20180291021
    Abstract: The invention relates to pyrridinobenzodiazepines (PDDs) comprising three fused 6-7-6-membered rings linked to aromatic groups, and pharmaceutically acceptable salts thereof, which are useful as medicaments, such as anti-proliferative agents.
    Type: Application
    Filed: February 21, 2018
    Publication date: October 11, 2018
    Inventors: Paul Joseph Mark JACKSON, David Edwin Thurston, Khondaker Mirazur Rahman
  • Patent number: 10079757
    Abstract: Techniques for providing access control in environments that may become disconnected, as a whole, from other networks (e.g., on-board a vehicle) may include locally storing access control information within the dis-connectable environment, and locally providing discovery and authentication/authorization services. Local services and/or applications may be registered and authenticated and client applications may be authenticated and/or authorized to one or more locally provided services and/or applications even when the environment is in a disconnected state. Local access control information may be synchronized with source access control information stored externally to the environment (e.g., on the ground).
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: September 18, 2018
    Assignee: GOGO LLC
    Inventors: Mark Jackson, Christopher M. Rippe, Michael Metz
  • Patent number: 9999625
    Abstract: The invention relates to pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) of formula (I) and in particular to PBD dimers linked through the C1 position, and PBD monomers linked through the C1 position to aromatic groups, and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: June 19, 2018
    Assignee: Femtogenix Limited
    Inventors: David Edwin Thurston, Khondaker Mirazur Rahman, Paul Joseph Mark Jackson
  • Publication number: 20180167655
    Abstract: Systems, methods, and computer-readable media are provided to assist users to locate content of interest based on viewer ratings. First information enabling unique identification of a first user may be processed. Indications of ratings of television programming may be processed, the indications being received from a first media device associated with the first user. Ratings information associated with the first user may be retained in repositories, the ratings information being based on the indications. The first user may be matched to a category that represents a classification of a set of viewers and/or of a set of content based on a set of attributes. Descriptive content indicative of the first user and/or content rated by the first user may be selected and may be transmitted via the network to a second media device associated with a second user.
    Type: Application
    Filed: January 25, 2018
    Publication date: June 14, 2018
    Inventors: Mark Jackson, Henry Gregg Martch
  • Publication number: 20180162855
    Abstract: The invention relates to pyrridinobenzodiazepines (PDDs) comprising three fused 6-7-6-membered rings and to benzopyrridodiazecines (BPDs) comprising three fused 6-8-6-membered rings and, in particular, to PDD or BPD dimers linked together or PDD and BPD monomers linked to aromatic groups, and pharmaceutically acceptable salts thereof, which are useful as medicaments, such as anti-proliferative agents.
    Type: Application
    Filed: June 9, 2016
    Publication date: June 14, 2018
    Inventors: David Edward THURSTON, Khondaker Mirazur RAHMAN, Paul Joseph Mark JACKSON
  • Patent number: 9994923
    Abstract: Neutralizing PCSK9 variants that interact with low density lipoprotein receptor (LDLR) are described. Methods and compositions for treating disorders by administering a pharmaceutically effective amount of a neutralizing PCSK9 variant are described.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: June 12, 2018
    Assignee: Amgen Inc.
    Inventors: Simon Mark Jackson, Derek Evan Piper
  • Publication number: 20180136545
    Abstract: A screen is provided. The screen includes: a substrate; an adhesive affixed to the substrate; and a mixture of reflective beads and transparent beads affixed by the adhesive to the substrate.
    Type: Application
    Filed: November 14, 2017
    Publication date: May 17, 2018
    Applicant: Magic Memories Innovation Limited
    Inventor: Kevin Mark Jackson
  • Publication number: 20180117033
    Abstract: Compositions and methods for treatment of conditions affecting skin and/or mucosal surfaces of a subject that make use of an imidazoquinoline compound and a retinoid agent are described.
    Type: Application
    Filed: November 15, 2017
    Publication date: May 3, 2018
    Inventor: J. Mark JACKSON
  • Patent number: 9920134
    Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: March 20, 2018
    Assignee: AMGEN INC.
    Inventors: Simon Mark Jackson, Nigel Pelham Clinton Walker, Derek Evan Piper, Bei Shan, Wenyan Shen, Joyce Chi Yee Chan, Chadwick Terrence King, Randal Robert Ketchem, Christopher Mehlin, Teresa Arazas Carabeo, Qiong Cao
  • Patent number: 9912973
    Abstract: Systems, methods, and computer-readable media are provided to assist users to locate content of interest based on viewer ratings. First information enabling unique identification of a first user may be processed. Indications of ratings of television programming may be processed, the indications being received from a first media device associated with the first user. Ratings information associated with the first user may be retained in repositories, the ratings information being based on the indications. The first user may be matched to a category that represents a classification of a set of viewers and/or of a set of content based on a set of attributes. Descriptive content indicative of the first user and/or content rated by the first user may be selected and may be transmitted via the network to a second media device associated with a second user.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: March 6, 2018
    Assignee: Echostar Technologies L.L.C.
    Inventors: Mark Jackson, Henry Gregg Martch
  • Publication number: 20180041999
    Abstract: Various embodiments of systems, devices, and methods are described for wireless communication. In one example a first wireless signal is received in a first radio frequency spectrum using a first antenna exterior to a building. The first wireless signal is associated with a first wireless protocol. The first wireless signal is converted into a first intermediate signal associated with a coaxial protocol. The first intermediate signal is transmitted to an interior of the building using a coaxial cable. The first intermediate signal is converted into a second signal associated with a second wireless protocol. The second signal is then transmitted in a second radio frequency spectrum using a second antenna interior to the building. The second signal is transmitted using the second wireless protocol.
    Type: Application
    Filed: August 4, 2016
    Publication date: February 8, 2018
    Inventors: Mark Jackson, Paul Langer
  • Publication number: 20180042065
    Abstract: Systems, devices, and methods are described for wireless communication. In one example a first wireless signal is received in a first radio frequency spectrum using a first antenna exterior to a building. The first wireless signal is associated with a first wireless protocol. The first wireless signal is converted into a first intermediate signal associated with a coaxial protocol. The first intermediate signal is transmitted to an interior of the building using a coaxial cable. The first intermediate signal is converted into a second signal associated with a second wireless protocol. The second signal is then transmitted in a second radio frequency spectrum using a second antenna interior to the building. The second signal is transmitted using the second wireless protocol.
    Type: Application
    Filed: August 3, 2017
    Publication date: February 8, 2018
    Inventors: Mark Jackson, Paul Langer
  • Patent number: 9849123
    Abstract: Compositions and methods for treatment of conditions affecting skin and/or mucosal surfaces of a subject that make use of an imidazoquinoline compound and a retinoid agent are described.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: December 26, 2017
    Assignee: 442 Ventures, LLC
    Inventor: J. Mark Jackson
  • Patent number: D854519
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: July 23, 2019
    Assignee: Hand Held Products, Inc.
    Inventors: Dean J. Bidwell, John S. Bandringa, Roger Jackson, Tim Zurmoehle, William Herweh, III, Churu Yun, Mark Oberpriller, Matthew McElvogue, Rajat Shail, Brian Moy